Your browser doesn't support javascript.
loading
[Progress in research of long-term protective efficacy of human papillomavirus vaccine].
Jia, X H; Kuang, X F; Chen, Y H; Li, Y F; Bi, Z F; Wu, T; Qiao, Y L.
Affiliation
  • Jia XH; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China Department of Epidemiology, National Cancer Center/National Clinical Researc
  • Kuang XF; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China Department of Epidemiology, National Cancer Center/National Clinical Researc
  • Chen YH; Yanjing Medical College, Capital Medical University, Beijing 101300, China.
  • Li YF; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China Department of Epidemiology, National Cancer Center/National Clinical Researc
  • Bi ZF; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China.
  • Wu T; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China.
  • Qiao YL; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China Center for Global Health, School of Population Medicine and Public Health, C
Zhonghua Liu Xing Bing Xue Za Zhi ; 44(5): 851-854, 2023 May 10.
Article in Zh | MEDLINE | ID: mdl-37221078
The efficacy of HPV vaccine in preventing cervical cancer has been demonstrated in numerous clinical trials and clinical uses. The follow-up after clinical trials usually last for 5-6 years to evaluate the long-term efficacy, and a series of long-term follow-up studies have been conducted in some regions. The literature retrieval of HPV vaccine long term efficiency research both at home and abroad indicated that the protective efficacy of the vaccine against vaccine-type-related cervical intraepithelial neoplasia grade 2 and above is higher than 90%.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomedical Research / Papillomavirus Vaccines Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: Zh Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2023 Document type: Article Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomedical Research / Papillomavirus Vaccines Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: Zh Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2023 Document type: Article Country of publication: China